COVID-19 vaccine candidate shows promising results in early testing

Taiwan's Adimmune Corporation said Wednesday that it has developed a COVID-19 vaccine candidate that has shown promising results in tests on lab rodents, and that it plans to begin human trials in the second half of this year.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)